Previous Close | 18.50 |
Open | 18.44 |
Bid | 0.00 x 1800 |
Ask | 0.00 x 800 |
Day's Range | 18.04 - 19.95 |
52 Week Range | 14.05 - 19.95 |
Volume | |
Avg. Volume | 4,353 |
Market Cap | 88.345M |
Beta (5Y Monthly) | 0.99 |
PE Ratio (TTM) | 24.53 |
EPS (TTM) | 0.81 |
Earnings Date | Nov 08, 2023 - Nov 13, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for FTLF
Omaha, NE, Sept. 27, 2023 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. (“FitLife” or the “Company”) (Nasdaq: FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced that the US Bankruptcy Court for the District of Nevada has approved FitLife’s acquisition of substantially all of the assets of MusclePharm Corporation under Section 363 of the US Bankruptcy Code. Highlights of the transaction are as follows: The all-cash transaction, with no shares
When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 15x, you may...
OMAHA, NE, Sept. 14, 2023 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. (“FitLife” or the “Company”) (OTC Pink: FTLF/Nasdaq: FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced that the Company has received approval to list its common stock on the Nasdaq Capital Market (“Nasdaq”). Trading on Nasdaq is expected to commence on Monday, September 18, 2023. The Company’s shares will continue to trade on OTC Pink until trading commences on Nasdaq.